calculator plugins (ChemAxon LLC)
90
Structured Review
ChemAxon LLC
calculator plugins
Calculator Plugins, supplied by ChemAxon LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plugins/calculator+plugins/pm30068171-180-0-16
Average 90 stars, based on 1 article reviews
Calculator Plugins, supplied by ChemAxon LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plugins/calculator+plugins/pm30068171-180-0-16
Average 90 stars, based on 1 article reviews
calculator plugins - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations Article Snippet: Calculator Plugins were used for structure property prediction and calculation, Article Title: Novel sigma 1-antagonists with cis -(+)-normetazocine scaffold: synthesis, molecular modeling, and antinociceptive effect. Article Snippet: A comprehensive computational prediction of the pharmacokinetic profile and brain/plasma distribution of compound 7 was conducted using the Article Title: NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations Article Snippet: NVL-655 Is a Selective and BrainPenetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Article Title: Novel sigma 1-antagonists with cis -(+)-normetazocine scaffold: synthesis, molecular modeling, and antinociceptive effect Article Snippet: A comprehensive computational prediction of the pharmacokinetic profile and brain/plasma distribution of compound 7 was conducted using the Article Title: Development of dual V1a/V2 antagonists containing triazolobenzazepine scaffold. Article Snippet: The development of a dual V1a/V2 antagonist compound is a complex and challenging task.. Conivaptan is up to now the only known V1a/V2 antagonist which was approved for the treatment of euvolemic hyponatremia.. Previously, we reported RGH-122, a novel selective V1a antagonist compound. Article Title: Synthesis and in vivo biological characterization of six carbon-11 sigma-1 receptor radiotracers in rodent and nonhuman primate. Article Snippet: Six enantiomers of three racemic sigma-1 receptor (σ1R) ligands were resolved, and absolute configuration was determined.. Their high σ1R potency and selectivity were determined through in vitro binding assays, further validated by molecular docking analysis.. Central Nervous System Multiparameter Optimization algorithm (CNS MPO) predicts efficient brain penetration for these enantiomers. Article Title: Enhanced anticancer effect of thymidylate synthase dimer disrupters by promoting intracellular accumulation Article Snippet: [3] "Calculator Plugins were used for structure property prediction and calculation, Activity Assay:Article Title: Enhanced anticancer effect of thymidylate synthase dimer disrupters by promoting intracellular accumulation Article Snippet: .. They have logD’s of −0.18 and −3.23 [“Calculator Plugins were used for structure property prediction and calculation, |